Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Michael McIntyre Reveals Slimmer Figure After Using Mounjaro - Featured image
Health & Wellness

Michael McIntyre Reveals Slimmer Figure After Using Mounjaro

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·November 8, 2025·2 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Michael McIntyre recently showcased his weight loss transformation in London, attributing it to the use of Mounjaro. He openly discussed his journey, including initial reluctance and subsequent positive results. He also commented on others using similar methods.

Share

Michael McIntyre Reveals Slimmer Figure After Using Mounjaro

Michael McIntyre recently unveiled his notable weight loss in London, sharing that he had been prescribed Mounjaro.

The comedian, 49, was photographed leaving Scott's restaurant in Mayfair on Friday afternoon. He sported navy suit trousers, a long black coat, and a fleece jacket as he stood outside the popular celebrity spot.

An onlooker recognized the presenter of The Wheel and approached him for a photograph. McIntyre happily obliged, engaging in a friendly chat and posing for pictures.

His weight loss was evident, showcasing a slimmer physique after recently discussing his use of Mounjaro, a weight-loss medication.

McIntyre openly shared that his weight had reached 100kg (15st 10lbs) before commencing the injections.

Furthermore, he humorously commented on celebrities who opt for such treatments, remarking that they sometimes 'look sh*t'.

McIntyre initiated weight loss injections following a doctor's warning that he was obese.

The presenter admitted initial hesitation towards the medication. However, his wife, Kitty, encouraged him to pursue it after the diagnosis.

McIntyre, whose weight has varied over time, explained that he initially used Ozempic before transitioning to Mounjaro, observing weight reduction within just three weeks. Health tracking apps like Shotlee can help monitor progress with weight loss medications.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

He commented, 'I do look a bit better now. I look good. I am kind of sexy now, a little bit. Not too much.'

He humorously addressed celebrities who 'cheat to be thin,' stating, 'I did it for three weeks, some people do it for years.'

'This is what is happening. Very big people have become very small people right?'

'And it does not suit everyone. Isn't that terrible when somebody loses all the weight they have been waiting to lose and they look a bit sh*t.

'Sometimes a big nose can be hidden by big cheeks and when the cheeks go down it is like "What the f*ck is going on?" and they are like a parrot.'

McIntyre maintained that his weight gain stemmed from consuming leftovers from his two sons, Lucas, 20, and Oscar, 18.

He also confessed that while the appetite suppressant was currently effective, he anticipated his progress would 'fall apart' if he succumbed to his sweet cravings again.

According to the NHS, a BMI between 30 and 39.9 indicates obesity for most adults, while a BMI above 40 signifies morbid obesity.

Source Information

Originally published by Daily Mail Online.Read the original article →

Read next

Keep exploring

More on Mounjaro

Articles covering Mounjaro dosing, side effects, and clinical updates.

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds
Health & Wellness

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds

A comprehensive guide to GLP-1 receptor agonists, understanding efficacy, managing side effects, and navigating the future of obesity treatment.

7 min read
Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation
Health & Wellness

Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation

The GLP-1 revolution is just the beginning. This article delves into the cutting-edge advancements poised to reshape the future of weight loss and metabolic health, offering insights for patients and observers alike.

7 min read
Beyond Weight Loss: The Next Wave of GLP-1 Drugs
Health & Wellness

Beyond Weight Loss: The Next Wave of GLP-1 Drugs

The revolutionary GLP-1 medications have transformed weight management, but the journey of innovation continues. Discover how upcoming drugs aim to enhance patient experience and outcomes.

7 min read

Same topic: weight management

All weight management articles →
Alli's Kidney Risk: FDA Updates Label for Over-the-Counter Weight Loss Pill
Health & Wellness

Alli's Kidney Risk: FDA Updates Label for Over-the-Counter Weight Loss Pill

The FDA has issued a critical update to the drug facts label for Alli, the only over-the-counter weight loss medication available in the U.S. The changes highlight rare but potentially severe kidney-related side effects, prompting new warnings for consumers.

7 min read
CagriSema Breakthrough: New Dual Therapy Delivers Major Weight Loss in Diabetes Trials
Diabetes & Metabolic Health

CagriSema Breakthrough: New Dual Therapy Delivers Major Weight Loss in Diabetes Trials

Explore the groundbreaking REIMAGINE trial results for CagriSema, a novel dual-agonist therapy showing superior glycemic control and weight loss in type 2 diabetes patients.

7 min read

More in Health & Wellness

Beyond Ozempic: A New Pill Targets Fat Metabolism Without Appetite Loss
Health & Wellness

Beyond Ozempic: A New Pill Targets Fat Metabolism Without Appetite Loss

A groundbreaking pill developed by researchers at Karolinska Institutet and Stockholm University offers a new avenue for treating type 2 diabetes and obesity. Unlike injectable GLP-1 agonists, this oral medication targets muscle metabolism to enhance fat burning and improve blood sugar control, aiming to circumvent common side effects.

7 min read
Ozempic & Beyond: Are GLP-1s Shifting America's Obesity Battle?
Health & Wellness

Ozempic & Beyond: Are GLP-1s Shifting America's Obesity Battle?

Once a distant rumor, the idea of widespread obesity in America is now being challenged by a new wave of medications. Discover how GLP-1 drugs are changing the landscape of weight management and what it means for public health.

8 min read
Share this article
  1. Home
  2. Blog
  3. Michael McIntyre Reveals Slimmer Figure After Using Mounjaro
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community